Schedule 13D ownership disclosure

THESEUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88369M101

Event date: 2021-10-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,212,732
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-127082
Form type
SC 13D
Filer
Foresite Capital Fund V, L.P.
CIK
CIK 1792204
Filed
Oct 18, 2021
Reporting period
Oct 07, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub